Two GZMB+ clusters (GZMB+ early-activation and GZMB+ late-activation/effector memory-like) displayed high expression of cytotoxicity markers, high TCR clonality and strong tumor association, evidenced by the significant overlaps of their TCRs with those identified in patient-matched tumor biopsies. This evidence concerns the gene GZMB and neoplasm.